Her doctors gave her a year to live, her breast cancer disappears in a clinical trial

Her doctors gave her a year to live, her breast cancer disappears in a clinical trial

If the survival rate of breast cancer can rise up to 90% in some high-income countriesit still remains deadliest cancer in women. And according to World Health Organization figures, “nearly one in twelve women will develop breast cancer in her lifetime”.

This is the case of Jasmin David, a 51-year-old Briton, who was diagnosed in November 2017 with an aggressive form of the disease. She discovers a few months later that her cancer spread “to the lungs, rib cage and lymph nodes”, reports The Independent. His doctors only give him a year to live.

Despite this announcement, Jasmin David, mother of two children, continues her chemotherapy sessions and undergoes a mastectomy in April 2018. She was then treated with radiotherapy, which finally rid her of her cancer. But in October 2019, the sickness come back.

As a last resort, David decides to join a clinical test phase 1 conducted over two years at the National Institute for Health and Care Research (NIHR) Clinical Research Facility (CRF) at the hospital The Christie of Manchesterknown as one of the largest cancer treatment centers in Europe.

During the test, she is invited to take a medication experimental “combined with an immunotherapy drug, atezolizumab, which she must inject every three weeks.” In June 2021, the verdict falls: his scanners no longer show any trace of cancer.

Very good results

“When I was offered the trial, I didn’t know if it would work for me,” she confides to the Manchester Evening News. “But I thought to myself that at least I could do something to help others and the next generation.” Despite many Side effects horrible, including headaches and temperature spikes”the body by Jasmin David finally begins to respond to the treatment.

“We are really happy that Jasmin had such a good result”comments Fiona Thistlethwaite, head of the clinical trial. “At The Christie, we are continually testing new drugs and therapies to see if they can benefit more people.”

If she should continue to follow the treatment until December 2023, David has now decided to take early retirement in order to enjoy his life to the full. “Two and a half years ago I thought it was the end, she remembers. Now I feel like I’m reborn.”

Leave a Comment

Your email address will not be published.